Literature DB >> 1452367

A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.

K T Mountzouros1, A Kimura, J L Cowell.   

Abstract

A mouse immunoglobulin G3 monoclonal antibody specific for the core oligosaccharide moiety of the lipooligosaccharide (LOS) of Bordetella pertussis has been shown to have complement-dependent bactericidal activity. This monoclonal antibody exhibits bactericidal activity against strains of B. pertussis that express the LOS A phenotype. In addition this monoclonal antibody was effective in reducing colonization by B. pertussis in both the lungs and tracheas of mice after aerosol infection.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1452367      PMCID： PMC258314          DOI： 10.1128/iai.60.12.5316-5318.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.

Authors:  J P Ackers; J M Dolby
Journal:  J Gen Microbiol       Date:  1972-04

2.  Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Authors:  Z M Li; J L Cowell; M J Brennan; D L Burns; C R Manclark
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

3.  Biological properties of lipopolysaccharides from Bordetella species.

Authors:  M Watanabe; H Takimoto; Y Kumazawa; K Amano
Journal:  J Gen Microbiol       Date:  1990-03

4.  Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A.

Authors:  D Archambault; P Rondeau; D Martin; B R Brodeur
Journal:  J Gen Microbiol       Date:  1991-04

5.  Structure of the terminal reducing heptasaccharide of polysaccharide 1 isolated from the Bordetella pertussis endotoxin.

Authors:  M Moreau; R Chaby; L Szabo
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

6.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

7.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Isolation of two protein-free and chemically different lipopolysaccharides from Bordetella pertussis phenol-extracted endotoxin.

Authors:  A Le Dur; R Chaby; L Szabó
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

9.  Aerosol infection of mice with Bordetella pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants.

Authors:  M S Peppler
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441
View more
  18 in total

1.  Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.

Authors:  K T Mountzouros; A P Howell
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Toward a new vaccine for pertussis.

Authors:  John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

Review 4.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.

Authors:  B R Brodeur; D Martin; J Hamel; R D Shahin; C Laferrière
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis.

Authors:  P McNicol; S M Giercke; M Gray; D Martin; B Brodeur; M S Peppler; T Williams; G Hammond
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Teresa Lagergård; Ariel Ginzberg; Jerry D King; Andrew Preston; Duncan J Maskell; Vince Pozsgay; Jerry M Keith; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

8.  Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.

Authors:  B Trollfors; T Lagergård; J Taranger; E Bergfors; R Schneerson; J B Robbins
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

9.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Gil Ben-Menachem; Vince Pozsgay; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2008-05-20       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.